Pegylated liposomal doxorubicin is active in Stewart-Treves syndrome.
Tassone
P
P
Tagliaferri
P
P
Cucinotto
I
I
Lavecchia
A M
AM
Leone
F
F
Pietragalla
A
A
Salvino
A
A
Barbieri
V
V
Venuta
S
S
D000369:Aged, 80 and over; D001706:Biopsy; D001943:Breast Neoplasms / Q000473:pathology / Q000601:surgery*; D062109:Dermatologic Surgical Procedures; D004317:Doxorubicin / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008081:Liposomes; D008209:Lymphedema / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D015409:Mastectomy, Radical / Q000009:adverse effects; D011092:Polyethylene Glycols / Q000008:administration & dosage* / Q000009:adverse effects; D011859:Radiography; D021701:Sentinel Lymph Node Biopsy; D016896:Treatment Outcome
D008081:Liposomes; C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D004317:Doxorubicin